Decreased Cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients

International Immunopharmacology

Volumn 5, Issue 1, 2005, Pages 103-106

  Ozaki, Kikumi S ^a   Câmara, Niels O S ^a   Galante, Nelson Z ^a   Camargo, Luiz F A ^a   Pacheco Silva, Alvaro ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytomegalovirus; Renal transplantation; Sirolimus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; ANTIGENS, CD3; ANTILYMPHOCYTE SERUM; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SIROLIMUS; T-LYMPHOCYTES;

EID: 10344241974     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.09.008     Document Type: Article

References (10)

1. P.L. Hibberd, N.E. Tolkoff-Rubin, A.B. Cosimi, R.T. Schooley, D. Isaacson, and M. Doran Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3 Transplantation 53 1992 68 72
2. D.R.J. Kuypers, B.D. Maes, W. Coosemans, J. Pirenne, and Y.F.C. Vanrenterghem Role of immunosuppressive drugs in the development of tissue-invasive Cytomegalovirus infection in renal transplant recipients Transplant. Proc. 34 2002 1164
3. B.D. Kahan The Rapamune US Study Group Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicenter study Lancet 356 2002 194
4. R.T. Abraham, and G.J. Wiederrecht Immunopharmacology of rapamycin Annu. Rev. Immunol. 14 1996 483
5. C.G. Groth, L. Backman, J.M. Morales, R. Calne, H. Kreis, and P. Lang Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group Transplantation 67 1999 1036 1042
6. H. Kreis, J.M. Cisterne, W. Land, L. Wramner, J.P. Squifflet, and D. Abramowicz Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients Transplantation 69 2000 1252 1260
7. L.F. Camargo, D.E. Uip, A.A. Simpson, O. Caballero, N.A. Stolf, and L.S. Vilas-Boas Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation Transplantation 71 2001 412 417
8. T.C. Bailey, W.G. Powderly, G.A Storch, S.B. Miller, J.D. Dunkel, and R.S. Woodward Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis Am. J. Kidney Dis. 21 1993 196 201
9. C. Couchoud, M. Cucherat, M. Haugh, and C. Pouteil-Noble Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis Transplantation 65 1998 641 647
10. R.A. Johnson, X. Wang, X.L. Ma, S.M. Huong, and E.S. Huang Human Cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus induced signaling J. Virol. 75 2000 6022